Loading organizations...
Samyang Holdings operates as a diversified conglomerate, active in chemical manufacturing, food production, and pharmaceuticals. Its chemical division supplies industrial materials, like terephthalic acid and engineering plastics, for various applications. The company also operates substantial food and pharmaceutical businesses, providing consumer and specialized products across diverse market segments to meet broad demands.
The company was founded in 1924 by Sudang Kim Yeon-su. It began as Samsu Company, an agricultural venture managing Jangseong Farm, reflecting Kim Yeon-su's insight to build a business rooted in essential resources. This foundational approach supported early growth and expansion. Renamed Samyang Corporation in 1931, the enterprise subsequently diversified into multiple industrial sectors, laying the groundwork for its current structure.
Samyang Holdings serves diverse industrial and consumer clients across its varied segments. Its mission prioritizes continuous innovation and delivering value through a comprehensive product portfolio. The company holds a forward-looking vision for sustained growth and development, aiming to contribute significantly to life and industry through strategic, multifaceted operations and ongoing commitment to progress.
Samyang Holdings has 1 tracked investment across 1 company. The latest tracked deal is $16.0M Series B in PharmCADD in April 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 19, 2021 | PharmCADD | $16.0M Series B | Huons, Samyang Holdings, SD BIOSENSOR | Daily Partners, DSC Investment, Future Play, KB Securities, KTB Network, Maple Investment |